Skip to content
Sonic
AI
Sonic
AI
Home
Discover
Ask Sonic
Projects
Use with Claude or ChatGPT
Show me around
Request source or feature
Joe Betts-LaCroix, Sonic AI
Home
/
Discover
/
Joe Betts-LaCroix
J
Joe Betts-LaCroix
Person
6
Mentions
Episodes
6
Claims
Claims
By Source
Timeline
All
(6)
Business
(2)
Healthcare
(3)
Government
(0)
Tech
(1)
Energy
(0)
Science
(0)
Geopolitics
(0)
The U.S. FDA has approved two clinical trials for "aging" as an indication, which function as basket trials for multiple age-related diseases.
Expert perspective
Joe Betz-Lacroix
Jun 22
Joe Betz-Lacroix predicts that within the next five years, Retro Biosciences will have one approved therapeutic on the market and a total of four therapeutics in human testing.
Speculative
Joe Betz-Lacroix
Jun 22
Retro Biosciences' molecule RTR-242, which is designed to restart the autophagy process in aged neurons, is most of the way through its first clinical trial.
Expert perspective
Joe Betz-Lacroix
Jun 22
Approximately 85% of all diseases treated in U.S. hospitals are age-related.
Expert perspective
Joe Betz-Lacroix
Jun 22
Retro Biosciences was seed-funded by Sam Altman and has collaborated with OpenAI to create models that generate novel proteins.
Expert perspective
Joe Betz-Lacroix
Jun 22
The use of generative AI tools has doubled the day-to-day productivity at Retro Biosciences.
Expert perspective
Joe Betz-Lacroix
Jun 22
Sign up free to see the full entity analysis
Get started free
Back to Entities
Entity Detail